December 10 A-share investment risk avoidance | Shenzhen SDG Service: Shareholder Silver Kun Company and Longxin Construction plan to collectively shareholding not exceeding 2%.

Hainan Poly Pharm: Currently under investigation by the Securities Regulatory Commission. There is a risk of being subjected to compulsory delisting due to major illegal activities involving stocks.

Gelonghui FinanceDec 9 09:20 ET

Hainan Poly Pharm (SZSE:300630) Adds CN¥615m to Market Cap in the Past 7 Days, Though Investors From Three Years Ago Are Still Down 77%

Simply Wall StDec 2 18:01 ET

Puli Pharmaceuticals: Third Quarter Report 2024 (after correction)

SZSINov 4 06:42 ET · Announcements

Puli Pharmaceuticals: Corrections to the 2024 Third Quarter Report

SZSINov 4 06:42 ET · Announcements

Hainan Poly Pharm (SZSE:300630) Is Making Moderate Use Of Debt

Simply Wall StNov 4 00:51 ET

Puli Pharmaceuticals: Report for the third quarter of 2024

SZSIOct 27 12:00 ET · Announcements